Company: PRME
Filing Date: 2025-02-28
Form Type: 8-K
Source: 0001628280-25-008873
Chunk: 1

Company: Prime Medicine, Inc.
Filing Date: 2025-02-28
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                  
   Number                                                                                   
     99.1      Press Release, dated F ebruary 28, 2025, furnished herewith.                 
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 28, 2025

  Prime Medicine, Inc.                                             
  By:                       /s/ Keith Gottesdiener                 
  Name:                     Keith Gottesdiener, M. D.              
  Title:                    President and Chief Executive Officer